Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
das181 (11 trials)
lactose (4 trials)
Asthma (Phase 1)
Bronchiectasis (Phase 1)
Communicable Diseases (Phase 3)
Infections (Phase 3)
Influenza, Human (Phase 2)
Paramyxoviridae Infections (Phase 3)
Respiratory Tract Infections (Phase 3)
Trials (11 total)
Trial APIs (2 total)